# Surrozen Inc. (SRZN) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $30.12, market value $527 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Surrozen Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 45.8×**. Each dollar of revenue is priced at 45.8×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -6.6%** (5-yr avg -105.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -385.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Return on equity: 128.9%**. A 128.9% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on assets: -336.4%**. Each dollar of assets produces -336.4% of profit.

## Growth
- **Revenue growth (1 yr): -67.4%** (3-yr -34.7%/yr). Revenue fell 67.4% over the last year.
- **EPS growth (1 yr): -49.4%**. Earnings per share fell 49.4%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 9.22** (quick 9.22). Current assets cover the next year's liabilities 9.22 times.
- **Altman Z-score: -1.94**. A Z-score of -1.94 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Surrozen Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 107.3%** (YTD 28.4%, 3-mo 33.2%). The shares are up 107.3% over twelve months including dividends.
- **From 52-week high: -20.4%** (164.4% above the low). Trading 20% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 58**. An RSI of 58 is neutral.
- **Beta (1 yr): 1.46** (volatility 135%). Beta of 1.46 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SRZN · Page: https://foliofundamentals.com/stocks/srzn

Not investment advice.